When big infrastructure projects spring up, one crucial law — the National Environmental Policy Act — has for decades been a ...

Cancer continues to be a substantial global health issue. By customizing prevention, diagnosis, and treatment plans depending on individual patient genetic ...

In a statement on Monday, Celcuity Inc. (NASDAQ:CELC) said it achieved positive topline results from the phase 3 clinical ...

Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today welcomes the White House’s release of “Winning the Race: America’s AI Action Plan”, issued July 23, 2025. The Company applauds ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is one of the Stocks With Huge Catalysts on the Horizon. On July 25, KalVista ...

Investing.com -- PTC (NASDAQ: PTC) Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) ...

The global In Vitro Fertilization Market is valued at USD 28.12 Billion in 2024 and is projected to reach a value of USD 63.7 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 7.75% between ...

Merck & Co., Inc. (MRK) on Tuesday narrowed its full-year earnings outlook and announced a restructuring programme aimed at ...

Investment management company Curreen Capital released its second-quarter 2025 Investor letter. A copy of the letter can be downloaded here. In the second quarter, Curreen Capital was up 14.07% vs. 10 ...